Flory T. Muanda

919 total citations
39 papers, 498 citations indexed

About

Flory T. Muanda is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Flory T. Muanda has authored 39 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 8 papers in Public Health, Environmental and Occupational Health and 7 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Flory T. Muanda's work include Pneumocystis jirovecii pneumonia detection and treatment (6 papers), Pregnancy and Medication Impact (5 papers) and Pharmacovigilance and Adverse Drug Reactions (5 papers). Flory T. Muanda is often cited by papers focused on Pneumocystis jirovecii pneumonia detection and treatment (6 papers), Pregnancy and Medication Impact (5 papers) and Pharmacovigilance and Adverse Drug Reactions (5 papers). Flory T. Muanda collaborates with scholars based in Canada, United States and United Kingdom. Flory T. Muanda's co-authors include Anick Bérard, Odile Sheehy, Amit X. Garg, Eric McArthur, Matthew A. Weir, Sonia Chaabane, Takoua Boukhris, Stephanie N. Dixon, Jessica M. Sontrop and Noha Iessa and has published in prestigious journals such as JAMA, PLoS ONE and Kidney International.

In The Last Decade

Flory T. Muanda

29 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Flory T. Muanda Canada 12 179 120 84 79 55 39 498
Susan W. Andersson Sweden 11 127 0.7× 128 1.1× 133 1.6× 143 1.8× 74 1.3× 14 466
L T W de Jong-van den Berg Netherlands 13 187 1.0× 179 1.5× 22 0.3× 77 1.0× 89 1.6× 24 670
Vytautas Kasiulevičius Lithuania 10 69 0.4× 44 0.4× 62 0.7× 96 1.2× 15 0.3× 47 528
Chiu-Ching Huang Taiwan 14 41 0.2× 142 1.2× 58 0.7× 183 2.3× 140 2.5× 21 596
Xiaolan Ren China 13 71 0.4× 31 0.3× 49 0.6× 98 1.2× 26 0.5× 34 560
Amy C. Wilson United States 17 123 0.7× 131 1.1× 23 0.3× 70 0.9× 31 0.6× 38 827
Marianne E Visser South Africa 16 118 0.7× 99 0.8× 16 0.2× 135 1.7× 19 0.3× 22 718
Pablo García United States 13 36 0.2× 36 0.3× 21 0.3× 75 0.9× 33 0.6× 33 532
Shital Bhandary Nepal 12 96 0.5× 45 0.4× 19 0.2× 29 0.4× 25 0.5× 93 436
Maleeka Ladhani Australia 8 117 0.7× 74 0.6× 50 0.6× 214 2.7× 17 0.3× 15 746

Countries citing papers authored by Flory T. Muanda

Since Specialization
Citations

This map shows the geographic impact of Flory T. Muanda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Flory T. Muanda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Flory T. Muanda more than expected).

Fields of papers citing papers by Flory T. Muanda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Flory T. Muanda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Flory T. Muanda. The network helps show where Flory T. Muanda may publish in the future.

Co-authorship network of co-authors of Flory T. Muanda

This figure shows the co-authorship network connecting the top 25 collaborators of Flory T. Muanda. A scholar is included among the top collaborators of Flory T. Muanda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Flory T. Muanda. Flory T. Muanda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McArthur, Eric, et al.. (2025). Trimethoprim-Sulfamethoxazole and Acute Respiratory Failure in Adolescents and Young Adults. JAMA Network Open. 8(11). e2545251–e2545251.
2.
Sedig, Kamran, et al.. (2025). Explainable AI for Clinical Decision Support Systems: Literature Review, Key Gaps, and Research Synthesis. Informatics. 12(4). 119–119. 3 indexed citations
3.
Tonial, Nicholas C., et al.. (2025). Adverse events with co‐prescription of angiotensin receptor blockers and clarithromycin compared to azithromycin: A population‐based retrospective cohort study. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 45(7). 414–425. 1 indexed citations
4.
Chalabianloo, Niaz, et al.. (2025). Machine learning methods for predicting adverse drug events: A systematic review. British Journal of Clinical Pharmacology. 92(2). 422–444.
5.
6.
7.
Muanda, Flory T., et al.. (2024). β‐Blockers and risk of neuropsychiatric disorders: A systematic review and meta‐analysis. British Journal of Clinical Pharmacology. 91(2). 325–337. 3 indexed citations
8.
Garg, Amit, Matthew A. Weir, Eric McArthur, et al.. (2024). Higher dose antiviral therapy for herpes infections is associated with a risk of serious adverse events in older adults with chronic kidney disease. Pharmacology Research & Perspectives. 12(6). e70028–e70028.
9.
10.
Garg, Amit X., Jessica M. Sontrop, Matthew A. Weir, et al.. (2022). Initiation Dose of Allopurinol and the Risk of Severe Cutaneous Reactions in Older Adults With CKD: A Population-Based Cohort Study. American Journal of Kidney Diseases. 80(6). 730–739. 4 indexed citations
11.
Muanda, Flory T., Manish M. Sood, Matthew A. Weir, et al.. (2022). Association of Higher-Dose Fluoroquinolone Therapy With Serious Adverse Events in Older Adults With Advanced Chronic Kidney Disease. JAMA Network Open. 5(8). e2224892–e2224892. 10 indexed citations
12.
Clemens, Kristin K., et al.. (2021). Trends in basal insulin prescribing in older adults with chronic kidney disease in Ontario, Canada: A population‐based analysis from 2010 to 2020. Diabetes Obesity and Metabolism. 24(4). 641–651. 1 indexed citations
13.
Jeyakumar, Nivethika, Eric McArthur, Jamie L Fleet, et al.. (2020). Hypocalcemia Risk of Denosumab Across the Spectrum of Kidney Disease: A Population-Based Cohort Study. Journal of Bone and Mineral Research. 38(5). 650–658. 18 indexed citations
14.
Rej, Soham, Nathan Herrmann, Andrea Gruneir, et al.. (2020). Association of Lithium Use and a Higher Serum Concentration of Lithium With the Risk of Declining Renal Function in Older Adults. The Journal of Clinical Psychiatry. 81(5). 15 indexed citations
15.
16.
Muanda, Flory T., Matthew A. Weir, Peter G. Blake, et al.. (2019). Association of Baclofen With Encephalopathy in Patients With Chronic Kidney Disease. JAMA. 322(20). 1987–1987. 48 indexed citations
17.
Muanda, Flory T., Odile Sheehy, & Anick Bérard. (2017). Use of antibiotics during pregnancy and the risk of major congenital malformations: a population based cohort study. British Journal of Clinical Pharmacology. 83(11). 2557–2571. 73 indexed citations
18.
Muanda, Flory T., Odile Sheehy, & Anick Bérard. (2017). Use of antibiotics during pregnancy and risk of spontaneous abortion. Canadian Medical Association Journal. 189(17). E625–E633. 82 indexed citations
19.
Muanda, Flory T., Sonia Chaabane, Takoua Boukhris, et al.. (2015). Antimalarial drugs for preventing malaria during pregnancy and the risk of low birth weight: a systematic review and meta-analysis of randomized and quasi-randomized trials. BMC Medicine. 13(1). 193–193. 19 indexed citations
20.
Bérard, Anick, Noha Iessa, Sonia Chaabane, et al.. (2015). The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta‐analysis. British Journal of Clinical Pharmacology. 81(4). 589–604. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan W. Andersson Breakdown of academic impact, for papers by L T W de Jong-van den Berg Breakdown of academic impact, for papers by Vytautas Kasiulevičius Breakdown of academic impact, for papers by Chiu-Ching Huang Breakdown of academic impact, for papers by Xiaolan Ren Breakdown of academic impact, for papers by Amy C. Wilson Breakdown of academic impact, for papers by Marianne E Visser Breakdown of academic impact, for papers by Pablo García Breakdown of academic impact, for papers by Shital Bhandary Breakdown of academic impact, for papers by Maleeka Ladhani
Rankless by CCL
2026